Patents by Inventor Mathiyazhagan RENGASAMY

Mathiyazhagan RENGASAMY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10471101
    Abstract: The present disclosure relates to composition comprising pooled and expanded allogeneic mesenchymal Stromal cells (MSCs) and a method for management of Ischemia using the composition thereof. In particular, the disclosure relates to bone marrow derived pooled and expanded allogeneic MSC compositions with effective dosage ranges and modes/route of administration for effective management of Ischemia. The disclosure also relates to the use of conditioned medium rich in bioactive factors in combination with the cell composition for managing ischemic conditions.
    Type: Grant
    Filed: March 25, 2015
    Date of Patent: November 12, 2019
    Assignee: Stempeutics Research PVT. LTD.
    Inventors: Anish Sen Majumdar, Pawan Kumar Gupta, Anoop Chullikana House, Sudha Balasubramanian, Charan Thej, Mathiyazhagan Rengasamy
  • Publication number: 20170100434
    Abstract: The present disclosure relates to composition comprising pooled and expanded allogeneic mesenchymal Stromal cells (MSCs) and a method for management of Ischemia using the composition thereof. In particular, the disclosure relates to bone marrow derived pooled and expanded allogeneic MSC compositions with effective dosage ranges and modes/route of administration for effective management of Ischemia. The disclosure also relates to the use of conditioned medium rich in bioactive factors in combination with the cell composition for managing ischemic conditions.
    Type: Application
    Filed: March 25, 2015
    Publication date: April 13, 2017
    Inventors: Anish Sen MAJUMDAR, Pawan Kumar GUPTA, Anoop CHULLIKANA HOUSE, Sudha BALASUBRAMANIAN, Charan THEJ, Mathiyazhagan RENGASAMY
  • Publication number: 20160184364
    Abstract: The present disclosure relates to a composition and method for management of Osteoarthritis, including improvement in pain and cartilage regeneration of knee joint affected by osteoarthritis. The present disclosure also relates to a kit for treating Osteoarthritis and the method of assembling the same. The present disclosure relates to a pooled allogeneic mesenchymal stromal cell composition from multiple donors with diverse HLA genotypes suitable for transplantation into a diverse population without the risk of rejection. The pooled cell composition of the present disclosure shows increased potency and higher chondrogenic differentiation potential.
    Type: Application
    Filed: August 14, 2014
    Publication date: June 30, 2016
    Applicant: STEMPEUTICS RESEARCH PVT. LTD.
    Inventors: Pawan Kumar GUPTA, Anoop Chullikana HOUSE, Anjan Kumar DAS, Anish Sen MAJUMDAR, Swathi Sundar RAJ, Sudha BALASUBRAMANIAN, Mathiyazhagan RENGASAMY